Alibaba Health Information Technology Ltd.

As of March 31, 2026, Alibaba Health Information Technology Ltd. carries a market capitalization of 8.25B, placing it among publicly traded companies globally. Its enterprise value stands at 6.98B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Alibaba Health Information Technology Ltd.'s next confirmed earnings release is scheduled for December 1, 2026.

As of March 31, 2026, Alibaba Health Information Technology Ltd. has 16.18B shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Alibaba Health Information Technology Ltd. maintains a current ratio of 3.03, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Alibaba Health Information Technology Ltd.'s stock has declined approximately 52.47% over the past 52 weeks. The 50-day moving average sits at 0.34, while the 200-day moving average is 0.46.

As of March 31, 2026, Alibaba Health Information Technology Ltd. holds 1.27B in cash and equivalents against 7.49M in total debt, resulting in a net debt position of -681.56M. Total book value stands at 2.24B, with working capital of 1.30B providing operational flexibility.